Skip to main content
Amble

By the numbers

GLP-1 weight loss, by the numbers

Last updated

Published research shows GLP-1 medications produce average weight loss of up to 22.5% of body weight, and first-time prescribing for obesity is rising fast.

This Amble Health research page collects the strongest published GLP-1 statistics in one place, from Johns Hopkins, Drugs.com, the OASIS 4 oral pill trial, KFF, and a 2026 prescribing analysis of Truveta health records. Each figure links to or names its source so you can check it.

The direct answer

How much weight do people lose on GLP-1?

Averages depend on the drug, the dose, and whether people stay on treatment. Tirzepatide shows average losses of up to 22.5% of body weight, and semaglutide up to 21% with certain formulations and doses, according to Drugs.com. In real-world use, a Johns Hopkins analysis found average losses of 10.88% for women and 6.78% for men.

Published GLP-1 statistics

GLP-1 statistics from our audit, with sources
DetailFigureSource
Tirzepatide average lossUp to 22.5% of body weightDrugs.com
Semaglutide average lossUp to 21% with certain formulations and dosesDrugs.com
2024 meta-analysis53 studies, 21,349 patients; tirzepatide worked best versus placeboDrugs.com
Oral pill, taken as directed16.6% average loss over 64 weeks, versus roughly 3% on placeboOASIS 4, reported with FDA approval of first oral GLP-1 pill
Oral pill, all participantsAbout 13.6% over 64 weeksOASIS 4
Women vs men10.88% vs 6.78% average lossJohns Hopkins, 2026
U.S. adults who have taken a GLP-1Roughly 1 in 8KFF Health Tracking Poll
First-time obesity prescribingUp 21.7%, Dec 2025 to Mar 2026medRxiv
First-time obesity semaglutideUp more than 50% in the same quartermedRxiv
Overall GLP-1 prescribing rates rose 15.0% from December 2025 to March 2026, the largest quarter-over-quarter increase since the study began in 2019.
GLP-1 RA Prescribing Trends, March 2026 data, medRxiv

Effectiveness

The method works across groups

The Johns Hopkins 2026 analysis found GLP-1 weight loss drugs comparably effective across age, race, and starting weight. Women lost about 11% of starting weight on average and men about 7%, a statistically significant difference. For anyone deciding whether medical weight loss is worth trying, the takeaway is that these results were not limited to one narrow group of patients.

Access

Demand is rising, and cost is the barrier

According to the KFF Health Tracking Poll, roughly 1 in 8 U.S. adults have taken a GLP-1. A 2026 analysis found first-time anti-obesity prescribing rose 21.7% in a single quarter. Amble Health's flat pricing from $135 per month and the Amble Cares Program, at up to 50% lower cost for eligible low-income patients, address the cost barrier directly.

Context

What these numbers mean for you

Averages are not promises; individual results vary. The strongest trial numbers come from people who stayed on treatment as directed for more than a year, which is why support and a sustainable plan matter. Read which GLP-1 is best for weight loss, or return to the guide to buying GLP-1 online.

Common questions

See all 50 questions
Which GLP-1 is best for weight loss?
Published research points to tirzepatide for the largest average weight loss, with averages of up to 22.5% of body weight. Semaglutide follows with averages of up to 21% with certain formulations and doses. The best choice for you depends on your history, which a provider reviews.
How much weight can I lose in 3 months on GLP-1?
Weight loss is gradual and varies from person to person, and the first weeks usually involve low starting doses. Trial averages are reported over 64 to 72 weeks rather than 3 months. Your provider can set realistic expectations based on your plan and how you respond.
How long does it take to lose 20 pounds on GLP-1?
There is no fixed timeline, because results depend on your starting weight, dose, diet, and activity. Analysis found average losses of about 11% of starting weight for women and about 7% for men. Use your check-ins with your provider to track progress.
Are GLP-1 pills as effective as injections?
Oral options now exist, and in the OASIS 4 trial adults who took the daily semaglutide pill as directed lost an average of 16.6% of body weight over 64 weeks. The pill must be taken on an empty stomach with a wait of about 30 minutes before eating. Once-weekly injections are offered, which avoid that daily routine.
How long will I need to stay on GLP-1 medication?
It depends on your goals and your provider’s recommendation. Published trials show the strongest average results among people who stayed on treatment for the full study, often 64 to 72 weeks. Talk with your provider before stopping or changing your plan.
Has anyone kept the weight off after stopping Wegovy?
Results after stopping vary from person to person. People who keep the habits they built during treatment, such as regular protein, strength training, and steady meal patterns, give themselves the best chance. Talk with your provider before stopping so you have a plan.

Turn the research into a plan

Take Amble's free quiz on joinamble.com and talk to a licensed provider.

Visit joinamble.com